Beijing SL Pharmaceutical Co., Ltd. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 826.97 million compared to CNY 913.38 million a year ago. Revenue was CNY 826.97 million compared to CNY 913.38 million a year ago.

Net income was CNY 237.95 million compared to CNY 435.94 million a year ago. Basic earnings per share from continuing operations was CNY 0.2316 compared to CNY 0.4243 a year ago. Diluted earnings per share from continuing operations was CNY 0.2316 compared to CNY 0.4243 a year ago.